LGBTQ+ social network company Grindr Inc (NYSE: GRND) announced on Monday that it has collaborated with Equality Movement and MPOWER to launch at-home HIV self-test kits for Grindr users in Georgia and Ireland.
This initiative, marking European testing week, extends Grindr's commitment to overcoming barriers to HIV testing, particularly for users facing challenges like rural residence or privacy concerns. The partnerships allow Grindr users in these countries to order free at-home HIV self-test kits directly through the app, offering a convenient and discreet option for health protection.
Grindr's history of promoting Equality Movement and MPOWER's home self-testing programs underscores its dedication to community-level interventions and judgment-free resources. This expansion follows Grindr's successful Together TakeMeHome program, in collaboration with Building Healthy Online Communities and Emory University, which distributed over 232,262 test kits within its first six months, emphasizing Grindr's commitment to similar global initiatives.
With over 13 million monthly active users globally, Grindr remains focused on fostering connections, self-expression and community support.
Gilead's lenacapavir demonstrates 100% efficacy in HIV prevention trial
Gilead study suggests lenacapavir superior to Truvada
Oxford BioDynamics announces opening of clinical testing facility in UK for prostate screening test
Takeda's HyQvia approved for maintenance therapy in CIDP patients
Allurion's Gastric Balloon introduced at Somerset NHS Foundation Trust for pre-surgical weight loss
Takeda's HYQVIA gains FDA approval for CIDP maintenance therapy
ANGLE signs USD250,000 contract with Eisai for HER2 assay pilot study
genedrive secures initial overseas orders for Genedrive MT-RNR1 ID kit
Kromek collaborates on next-gen CT detector technology
Gilead Sciences initiates Phase 2 trial in Europe to evaluate lenacapavir for HIV prevention
European Commission grants authorisation to ViiV Healthcare's Apretude for prevention of HIV
Celanese to supply VitalDose drug delivery platform for Population Council's MPT Intravaginal Ring